258 related articles for article (PubMed ID: 35102287)
21. How bad is Omicron? What scientists know so far.
Callaway E; Ledford H
Nature; 2021 Dec; 600(7888):197-199. PubMed ID: 34857948
[No Abstract] [Full Text] [Related]
22. Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2022 Feb; 386(8):e27. PubMed ID: 35196435
[No Abstract] [Full Text] [Related]
23. Pfizer COVID vaccine protects against worrying coronavirus variants.
Callaway E
Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
[No Abstract] [Full Text] [Related]
24. Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
Abbasi J
JAMA; 2021 Dec; 326(24):2460-2462. PubMed ID: 34870691
[No Abstract] [Full Text] [Related]
25. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
[TBL] [Abstract][Full Text] [Related]
26. Six months of COVID vaccines: what 1.7 billion doses have taught scientists.
Ledford H
Nature; 2021 Jun; 594(7862):164-167. PubMed ID: 34089016
[No Abstract] [Full Text] [Related]
27. HIV and covid-19 in South Africa.
Freer J; Mudaly V
BMJ; 2022 Jan; 376():e069807. PubMed ID: 35086921
[No Abstract] [Full Text] [Related]
28. COVID-19: endemic doesn't mean harmless.
Katzourakis A
Nature; 2022 Jan; 601(7894):485. PubMed ID: 35075305
[No Abstract] [Full Text] [Related]
29. Audio Interview: The Omicron Variant of SARS-CoV-2.
Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
N Engl J Med; 2021 Dec; 385(23):e96. PubMed ID: 34874638
[No Abstract] [Full Text] [Related]
30. What the Omicron wave is revealing about human immunity.
Willyard C
Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764
[No Abstract] [Full Text] [Related]
31. UK science advisers: publish evidence behind COVID vaccine changes.
Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
[No Abstract] [Full Text] [Related]
32. How many COVID deaths are acceptable in a post-pandemic world?
Mallapaty S
Nature; 2021 May; 593(7859):326-327. PubMed ID: 33958788
[No Abstract] [Full Text] [Related]
33. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.
Abdullahi IN; Emeribe AU; Adekola HA; Abubakar SD; Dangana A; Shuwa HA; Nwoba ST; Mustapha JO; Haruna MT; Olowookere KA; Animasaun OS; Ugwu CE; Onoja SO; Gadama AS; Mohammed M; Daneji IM; Amadu DO; Ghamba PE; Onukegbe NB; Shehu MS; Isomah C; Babayo A; Ahmad AE
Hum Vaccin Immunother; 2021 Mar; 17(3):620-637. PubMed ID: 32936732
[TBL] [Abstract][Full Text] [Related]
34. Eight unanswered questions about the COVID-19 pandemic.
May M
Nat Med; 2021 Dec; 27(12):2058-2061. PubMed ID: 34907383
[No Abstract] [Full Text] [Related]
35. How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.
Ledford H
Nature; 2021 Jan; 589(7841):182. PubMed ID: 33437062
[No Abstract] [Full Text] [Related]
36. Multitude of coronavirus variants found in the US - but the threat is unclear.
Callaway E
Nature; 2021 Mar; 591(7849):190. PubMed ID: 33674807
[No Abstract] [Full Text] [Related]
37. Immunology Lessons from the SARS-CoV-2 Pandemic.
Yokoyama WM; Hogquist KA; O'Shea JJ
Annu Rev Immunol; 2021 Apr; 39():v-vii. PubMed ID: 33939926
[No Abstract] [Full Text] [Related]
38. Will SARS-CoV-2 variants of concern affect the promise of vaccines?
Gupta RK
Nat Rev Immunol; 2021 Jun; 21(6):340-341. PubMed ID: 33927376
[TBL] [Abstract][Full Text] [Related]
39. COVID vaccines slash viral spread - but Delta is an unknown.
Mallapaty S
Nature; 2021 Aug; 596(7870):17-18. PubMed ID: 34321643
[No Abstract] [Full Text] [Related]
40. Emerging concerns regarding COVID-19; second wave and new variant.
Hafeez S; Din M; Zia F; Ali M; Shinwari ZK
J Med Virol; 2021 Jul; 93(7):4108-4110. PubMed ID: 33851434
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
